<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: serotonin receptor</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New Clues about Genetic Influence of Stress on Men's Health</title>
   	 <description>Men with a common genetic variant produce more than twice as much of a hormone known to increase blood pressure and blood sugar when they are angry, according to researchers from Duke University Medical Center.</description>
     <link>http://www.physorg.com/news155572711.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 06 Mar 2009 14:39:18 EST</pubDate>
	 <guid isPermaLink="false">news155572711</guid>
</item>
<item>
     <title>Brain protein may be a target for fast-acting antidepressants</title>
   	 <description>(PhysOrg.com) -- It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person`s susceptibility to depression, activates a serotonin receptor in the brain known for producing a rapid antidepressant response. If scientists could develop drugs to target this receptor, they might produce an effect in as little as two days.</description>
     <link>http://www.physorg.com/news154800119.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 25 Feb 2009 16:03:28 EST</pubDate>
	 <guid isPermaLink="false">news154800119</guid>
</item>
<item>
     <title>Researchers find clue to safer obesity drugs</title>
   	 <description>(PhysOrg.com) -- Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.</description>
     <link>http://www.physorg.com/news146838003.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 25 Nov 2008 12:20:03 EST</pubDate>
	 <guid isPermaLink="false">news146838003</guid>
</item>


</channel>
</rss>

